The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change

Objective: The study compared the relative cost differences of similar orphan drugs among high and low GDP countries in Europe: Bulgaria, France, Germany, Greece, Hungary, Italy, Norway, Poland, Romania, Spain, Sweden, UK. Methods: Annual treatment costs per patient were calculated. Relative costs w...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, K. E., Soussi, I., Toumi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645904/
https://www.ncbi.nlm.nih.gov/pubmed/29081920
http://dx.doi.org/10.1080/20016689.2017.1369817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645904/
https://www.ncbi.nlm.nih.gov/pubmed/29081920
http://dx.doi.org/10.1080/20016689.2017.1369817

Ejemplares similares